FI  Lightchain Capital

https://www.lightchain-capital.com/





     Office Locations:

PO Box 31729
St. Louis, MO 63131

 

Stages:

  • Early


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Software & Internet

  •  

    Description:

    Lightchain Capital is the family office of Rodger Riney. Riney was the Founder and former CEO of discount brokerage firm Scottrade. According to Forbes, Riney is worth $3.5B. In the year after selling Scottrade, Riney donated $131 million to various causes. Riney actively supports non-profit organizations, including the Alzheimer's Association, the Humane Society of the United States, and the Salvation Army. Riney suffers from multiple myeloma and in 2017, he donated $5 million to fund research on the disease. In 2018, he donated $20 million to the Washington University School of Medicine. Lightchain's venture capital fund focuses investments on early-stage life sciences companies looking to improve people's outcomes with cancer.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Drew Dennison Managing Director
    Roger Riney Founder

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      11/19/2025


      AI Proteins


      MA


      $41,500,000


      Series A


      10/01/2025


      Predicta Biosciences


      MA


      $23,400,000


      Series A


      01/08/2025


      Geneoscopy


      MO


      $105,000,000


      Series C


     

    Portfolio companies include:


      Adarza BioSystems


      AI Proteins
        web link


      Arch Oncology


      C4 Therapeutics
        web link


      CareVet


      Geneoscopy
        web link


      MANA Therapeutics
        web link


      Microbial Machines


      NextRNA Therapeutics


      Predicta Biosciences
        web link


      Simple Rose


      Wugen


     

    Recent News: